Summary
Machine-generated summaryThis tender covers recurring supplies of medicinal products containing the active ingredient pembrolizumab. The procurement is for antineoplastic drugs and is located in the Czech Republic. The specific buyer, estimated value, deadline, and procedure type are not stated in the available information. Eligibility to bid and the procedure details are not specified in the provided tender notice.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile44 open tenders right now
- Medical needles - Echogenic needle 1 day left
- Vascular prostheses - Linear ePTFE vascular prosthesis 1 day left
- Czech Republic - Antineoplastic and immunomodulating agents - INTERFERON BETA-1A 2026 2 days left
Recent awards
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Status: Now marked as Closed
- Estimated value: Set to €20,548,463
- Submission deadline: Moved 1 day EARLIER: now July 16, 2026, 00:00
- Estimated value: Set to €497,272,797
Follow this tender and we email you the moment it changes. Create account
Similar tenders
1
day left
€453,875
est. value
1
day left
€1,349,560
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,674,558
- Buyer track record on Aperlena
- 761 notices tracked · 400 awarded
- €531,888,821 in awarded contracts
Never miss a tender like this
149 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert